As of November 2026 Retension Pharmaceuticals has a market cap of A$0.13 Billion. This makes Retension Pharmaceuticals the world's 9819th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 1st, 2026 the market cap of Retension Pharmaceuticals was reported to be: